Home/Filings/4/0001179110-20-007935
4//SEC Filing

Levy Lewis 4

Accession 0001179110-20-007935

CIK 0001477449other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:00 PM ET

Size

11.9 KB

Accession

0001179110-20-007935

Insider Transaction Report

Form 4
Period: 2020-07-01
Levy Lewis
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2020-07-01$189.90/sh2,670$507,0338,766 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-07-011,27525,264 total
    Exercise: $38.55Exp: 2028-03-01Common Stock (1,275 underlying)
  • Exercise/Conversion

    Common Stock

    2020-07-01$38.55/sh+1,275$49,15111,436 total
  • Exercise/Conversion

    Common Stock

    2020-07-01$35.45/sh+1,395$49,45310,161 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-07-011,39517,648 total
    Exercise: $35.45Exp: 2027-07-14Common Stock (1,395 underlying)
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2020.
  • [F2]The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
  • [F3]The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001726568

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:00 PM ET
Size
11.9 KB